Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature review

References

• Grzadzinski R, Huerta M, Lord C. DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Mol Autism. 2013;4(1):12.
   PubMedGoogle Scholar
• Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M, et al. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237–57.
   PubMed Web of Science ®Google Scholar
• LeClerc S, Easley D. Pharmacological therapies for autism spectrum disorder: a review. P T. 2015;40(6):389–97.
   PubMedGoogle Scholar
• Persico AM, Arango C, Buitelaar JK, Correll CU, Glennon JC, Hoekstra PJ, et al. Unmet needs in paediatric psychopharmacology: present scenario and future perspectives. Eur Neuropsychopharmacol. 2015;25(10):1513–31.
   PubMed Web of Science ®Google Scholar
• Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ. Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 national health interview survey. Natl Health Stat Report. 2015;87:1–20.
   Google Scholar
• Shailesh H, Gupta I, Sif S, Ouhtit A. Towards understanding the genetics of autism. Front Biosci (Elite Ed). 2016;8:412–26.
   PubMedGoogle Scholar
• Watts TJ. The pathogenesis of autism. Clin Med Pathol. 2008;1:99–103.
   PubMedGoogle Scholar
• Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14(3):281–92.
   PubMedGoogle Scholar
• Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol Autism. 2017;8:13.
   PubMed Web of Science ®Google Scholar
• Field SS. Interaction of genes and nutritional factors in the etiology of autism and attention deficit/hyperactivity disorders: a case control study. Med Hypotheses. 2014;82(6):654–61.
   PubMed Web of Science ®Google Scholar
• Agostoni C, Nobile M, Ciappolino V, Delvecchio G, Tesei A, Turolo S, et al. The role of omega-3 fatty acids in developmental psychopathology: a systematic review on early psychosis, autism, and ADHD. Int J Mol Sci. 2017;18(12):2608.
   PubMed Web of Science ®Google Scholar
• Cannell JJ. Vitamin D and autism, what’s new? Rev Endocr Metab Disord. 2017;18(2):183–93.
   PubMed Web of Science ®Google Scholar
• Jia F, Shan L, Wang B, Li H, Miao C, Xu Z, et al. Bench to bedside review: possible role of vitamin D in autism spectrum disorder. Psychiatry Res. 2018;260:360–5.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674–88.
   PubMed Web of Science ®Google Scholar
• Crupi R, Marino A, Cuzzocrea S. n-3 fatty acids: role in neurogenesis and neuroplasticity. Curr Med Chem. 2013;20(24):2953–63.
   PubMed Web of Science ®Google Scholar
• Parletta N, Milte CM, Meyer BJ. Nutritional modulation of cognitive function and mental health. J Nutr Biochem. 2013;24(5):725–43.
   PubMed Web of Science ®Google Scholar
• Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015;7:52.
   PubMed Web of Science ®Google Scholar
• Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology. 2013;64:550–65.
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Greiner RS, Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 2000;75(6):2563–73.
   PubMed Web of Science ®Google Scholar
• Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36(9):945–59.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Perry M, Sears B. Dissociation of C-reactive protein levels from long-chain omega-3 fatty acid status and antidepressant response in adolescents with major depressive disorder: An open-label dose-ranging trial. J Nut Ther. 2013;2:000–000.
   Google Scholar
• Parletta N, Niyonsenga T, Duff J. Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls. PLoS One. 2016;11(5):e0156432.
   PubMed Web of Science ®Google Scholar
• Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev. 2014;313570.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Welge JA. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. Bipolar Disord. 2016;18(3):300–6.
   PubMed Web of Science ®Google Scholar
• Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19(1):21–36.
   PubMed Web of Science ®Google Scholar
• Fontes JD, Rahman F, Lacey S, Larson MG, Vasan RS, Benjamin EJ, et al. Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort. Atherosclerosis. 2015;240(2):431–6.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365–79.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101.
   PubMed Web of Science ®Google Scholar
• Sears B. Anti-inflammatory diets. J Am Coll Nutr. 2015;34(Suppl 1):14–21.
   PubMedGoogle Scholar
• Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128.
   PubMed Web of Science ®Google Scholar
• Yang WH, Jing J, Xiu LJ, Cheng MH, Wang X, Bao P, et al. Regional cerebral blood flow in children with autism spectrum disorders: a quantitative ⁹⁹mTc-ECD brain SPECT study with statistical parametric mapping evaluation. Chin Med J (Engl). 2011;124(9):1362–6.
   PubMed Web of Science ®Google Scholar
• Dipasquale V, Cutrupi MC, Colavita L, Manti S, Cuppari C, Salpietro C. Neuroinflammation in autism spectrum disorders: role of high Mobility group Box 1 Protein. Int J Mol Cell Med. 2017;6(3):148–55.
   PubMed Web of Science ®Google Scholar
• van Elst K, Bruining H, Birtoli B, Terreaux C, Buitelaar JK, Kas MJ. Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. Neurosci Biobehav Rev. 2014;45:369–78.
   PubMed Web of Science ®Google Scholar
• Vancassel S, Durand G, Barthélémy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001;65(1):1–7.
   PubMed Web of Science ®Google Scholar
• Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr. 1990;51(6):1075–81.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
   PubMed Web of Science ®Google Scholar
• Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects. Eat Weight Disord. 2017;22(1):27–41.
   PubMed Web of Science ®Google Scholar
• Cannell JJ. Autism and vitamin D. Med Hypotheses. 2008;70(4):750–9.
   PubMed Web of Science ®Google Scholar
• Kesby JP, Eyles DW, Burne TH, McGrath JJ. The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol. 2011;347(1–2):121–7.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013;34(1):47–64.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.
   PubMed Web of Science ®Google Scholar
• Grant WB, Cannell JJ. Autism prevalence in the United States with respect to solar UV-B doses: An ecological study. Dermatoendocrinol. 2013;5(1):159–64.
   PubMedGoogle Scholar
• Gong ZL, Luo CM, Wang L, Shen L, Wei F, Tong RJ, et al. Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. Neuroreport. 2014;25(1):23–7.
   PubMed Web of Science ®Google Scholar
• Fernell E, Bejerot S, Westerlund J, Miniscalco C, Simila H, Eyles D, et al. Autism spectrum disorder and low vitamin D at birth: a sibling control study. Mol Autism. 2015;6(3).
   PubMedGoogle Scholar
• Endres D, Dersch R, Stich O, Buchwald A, Perlov E, Feige B, et al. Vitamin D deficiency in adult patients with Schizophreniform and autism spectrum Syndromes: A One-year Cohort study at a German tertiary care hospital. Front Psychiatry. 2016;7:168.
   PubMed Web of Science ®Google Scholar
• Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, et al. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2016;25(4):341–50.
   PubMed Web of Science ®Google Scholar
• Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, et al. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. 2016;19(8):346–51.
   PubMed Web of Science ®Google Scholar
• Feng J, Shan L, Du L, Wang B, Li H, Wang W, et al. Clinical improvement following vitamin D3 supplementation in autism spectrum disorder. Nutr Neurosci. 2017;20(5):284–90.
   PubMed Web of Science ®Google Scholar
• Grant WB, Soles CM. Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinol. 2009;1(4):223–8.
   PubMedGoogle Scholar
• Magnusson C, Lundberg M, Lee BK, Rai D, Karlsson H, Gardner R, et al. Maternal vitamin D deficiency and the risk of autism spectrum disorders: population-based study. BJPsych Open. 2016;2(2):170–2.
   PubMed Web of Science ®Google Scholar
• Huh SY, Gordon CM. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord. 2008;9(2):161–70.
   PubMed Web of Science ®Google Scholar
• Shin YH, Shin HJ, Lee YJ. Vitamin D status and childhood health. Korean J Pediatr. 2013;56(10):417–23.
   PubMedGoogle Scholar
• Cadario F, Savastio S, Rizzo AM, Carrera D, Bona G, Ricordi C. Can type 1 diabetes progression be halted? Possible role of high dose vitamin D and omega 3 fatty acids. Eur Rev Med Pharmacol Sci. 2017;21(7):1604–9.
   PubMedGoogle Scholar
• Rizzo AM, Montorfano G, Negroni M, Adorni L, Berselli P, Corsetto P, et al. A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies. Lipids Health Dis. 2010;9:7.
   PubMed Web of Science ®Google Scholar
• Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: childhood autism rating Scale (CARS). J Autism Dev Disord. 1980;10(1):91–103.
   PubMed Web of Science ®Google Scholar
• Chlebowski C, Green JA, Barton ML, Fein D. Using the childhood autism rating scale to diagnose autism spectrum disorders. J Autism Dev Disord. 2010;40(7):787–99.
   PubMed Web of Science ®Google Scholar
• Mesibov GB, Schopler E, Schaffer B, Michal N. Use of the childhood autism rating scale with autistic adolescents and adults. J Am Acad Child Adolesc Psychiatry. 1989;28(4):538–41.
   PubMed Web of Science ®Google Scholar
• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• Mozaffarian D. JELIS, fish oil, and cardiac events. Lancet. 2007;369(9567):1062–3.
   PubMed Web of Science ®Google Scholar
• Baidal DA, Ricordi C, Garcia-Contreras M, Sonnino A, Fabbri A. Combination high-dose omega-3 fatty acids and high-dose cholecalciferol in new onset type 1 diabetes: a potential role in preservation of beta-cell mass. Eur Rev Med Pharmacol Sci. 2016;20(15):3313–8.
   PubMed Web of Science ®Google Scholar
• Cadario F, Savastio S, Ricotti R, Rizzo AM, Carrera D, Maiuri L, et al. Administration of vitamin D and high dose of omega 3 to sustain remission of type 1 diabetes. Eur Rev Med Pharmacol Sci. 2018;22(2):512–5.
   PubMed Web of Science ®Google Scholar
• Sorgi PJ, Hallowell EM, Hutchins HL, Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J. 2007;6:16.
   PubMed Web of Science ®Google Scholar
• Osher Y, Belmaker RH. Omega-3 fatty acids in depression: a review of three studies. CNS Neurosci Ther. 2009;15(2):128–33.
   PubMed Web of Science ®Google Scholar
• Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163(6):1098–100.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007;61(4):551–3.
   PubMed Web of Science ®Google Scholar
• Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011;41(5):545–54.
   PubMed Web of Science ®Google Scholar
• Bent S, Hendren RL, Zandi T, Law K, Choi JE, Widjaja F, et al. Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry. 2014;53(6):658–66.
   PubMed Web of Science ®Google Scholar
• Mankad D, Dupuis A, Smile S, Roberts W, Brian J, Lui T, et al. A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Mol Autism. 2015;6:18.
   PubMed Web of Science ®Google Scholar
• Meiri G, Bichovsky Y, Belmaker RH. Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol. 2009;19(4):449–51.
   PubMed Web of Science ®Google Scholar
• Politi P, Cena H, Comelli M, Marrone G, Allegri C, Emanuele E, et al. Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. Arch Med Res. 2008;39(7):682–5.
   PubMed Web of Science ®Google Scholar
• Parellada M, Llorente C, Calvo R, Gutierrez S, Lázaro L, Graell M, et al. Randomized trial of omega-3 for autism spectrum disorders: effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017;27(12):1319–30.
   PubMed Web of Science ®Google Scholar
• Cheng YS, Tseng PT, Chen YW, Stubbs B, Yang WC, Chen TY, et al. Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat. 2017;13:2531–43.
   PubMed Web of Science ®Google Scholar
• Mazahery H, Stonehouse W, Delshad M, Kruger MC, Conlon CA, Beck KL, et al. Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case-control and randomised controlled trials. Nutrients. 2017;9(2):155.
   Web of Science ®Google Scholar
• Suppes T, Eberhard J, Lemming O, Young AH, McIntyre RS. Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials. Int J Bipolar Disord. 2017;5(1):36.
   PubMedGoogle Scholar
• Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry. 2009;70(8):1078–90.
   PubMed Web of Science ®Google Scholar
• Lotrich FE, Sears B, McNamara RK. Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids. J Psychosom Res. 2013;75(5):475–83.
   PubMed Web of Science ®Google Scholar
• Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr. 2009;63(8):1037–40.
   PubMed Web of Science ®Google Scholar
• Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):407–12.
   PubMed Web of Science ®Google Scholar
• Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics. 2015;135(1):e196–8.
   PubMed Web of Science ®Google Scholar
• Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, El-Houfey AA, Othman HA, et al. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry. 2018;59(1):20–9.
   PubMed Web of Science ®Google Scholar
• Jia F, Shan L, Wang B, Li H, Feng J, Xu Z, et al. Fluctuations in clinical symptoms with changes in serum 25(OH) vitamin D levels in autistic children: three cases report. Nutr Neurosci. 2018:1–4. doi:10.1080/1028415X.2018.1458421.
   PubMed Web of Science ®Google Scholar
• James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80(6):1611–7.
   PubMed Web of Science ®Google Scholar
• Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegaliński E, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep. 2015;67(3):569–80.
   PubMed Web of Science ®Google Scholar
• Szachta P, Skonieczna-Żydecka K, Adler G, Karakua-Juchnowicz H, Madlani H, Ignyś I. Immune related factors in pathogenesis of autism spectrum disorders. Eur Rev Med Pharmacol Sci. 2016;20(14):3060–72.
   PubMed Web of Science ®Google Scholar
• Mazur-Kolecka B, Cohen IL, Gonzalez M, Jenkins EC, Kaczmarski W, Brown WT, et al. Autoantibodies against neuronal progenitors in sera from children with autism. Brain Dev. 2014;36(4):322–9.
   PubMed Web of Science ®Google Scholar
• Hopperton KE, Trépanier MO, Giuliano V, Bazinet RP. Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice. J Neuroinflammation. 2016;13(1):257.
   PubMedGoogle Scholar
• Inoue T, Tanaka M, Masuda S, Ohue-Kitano R, Yamakage H, Muranaka K, et al. Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(5):552–60.
   Google Scholar
• Chen X, Wu S, Chen C, Xie B, Fang Z, Hu W, et al. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury. J Neuroinflammation. 2017;14(1):143.
   PubMedGoogle Scholar
• Cannell JJ. Autism, will vitamin D treat core symptoms? Med Hypotheses. 2013;81(2):195–8.
   PubMed Web of Science ®Google Scholar
• Huang YN, Ho YJ, Lai CC, Chiu CT, Wang JY. 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflammation. 2015;12:147.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Cheng Y, He M, Li T, Ma Z, Cheng H. Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: A randomized controlled trial. Exp Ther Med. 2016;12(3):1889–95.
   PubMed Web of Science ®Google Scholar
• Bakdash G, van Capel TM, Mason LM, Kapsenberg ML, de Jong EC. Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells. Vaccine. 2014;32(47):6294–302.
   PubMed Web of Science ®Google Scholar
• Kaneko I, Sabir MS, Dussik CM, Whitfield GK, Karrys A, Hsieh JC, et al. 1,25-Dihydroxyvitamin d regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. FASEB J. 2015;29(9):4023–35.
   PubMed Web of Science ®Google Scholar
• Jiang P, Zhang LH, Cai HL, Li HD, Liu YP, Tang MM, et al. Neurochemical effects of chronic administration of calcitriol in rats. Nutrients. 2014;6(12):6048–59.
   PubMed Web of Science ®Google Scholar
• Chakraborti B, Verma D, Karmakar A, Jaiswal P, Sanyal A, Paul D, et al. Genetic variants of MAOB affect serotonin level and specific behavioral attributes to increase autism spectrum disorder (ASD) susceptibility in males. Prog Neuropsychopharmacol Biol Psychiatry. 2016;71:123–36.
   PubMed Web of Science ®Google Scholar
• Robertson CE, Ratai EM, Kanwisher N. Reduced GABAergic action in the autistic brain. Curr Biol. 2016;26(1):80–5.
   PubMed Web of Science ®Google Scholar
• Wrzosek M, Łukaszkiewicz J, Jakubczyk A, Matsumoto H, Piątkiewicz P, Radziwoń-Zaleska M, et al. Vitamin D and the central nervous system. Pharmacol Rep. 2013;65(2):271–8.
   PubMed Web of Science ®Google Scholar
• Razavi M, Jamilian M, Samimi M, Afshar Ebrahimi F, Taghizadeh M, Bekhradi R, et al. The effects of vitamin D and omega-3 fatty acids co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in patients with gestational diabetes. Nutr Metab (Lond). 2017;14:80.
   PubMed Web of Science ®Google Scholar
• Mazahery H, Conlon C, Beck KL, Kruger MC, Stonehouse W, Camargo CA, et al. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial. Trials. 2016;17(1):295.
   PubMedGoogle Scholar
• Klingberg E, Oleröd G, Konar J, Petzold M, Hammarsten O. Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort. Endocrine. 2015;49(3):800–8.
   PubMed Web of Science ®Google Scholar
• Costanzo PR, Constanzo PR, Elías NO, Kleiman Rubinsztein J, García Basavilbaso NX, Piacentini R, et al. Ultraviolet radiation impact on seasonal variations of serum 25-hydroxy-vitamin D in healthy young adults in Buenos Aires. Medicina (B Aires). 2011;71(4):336–42.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okano T, Shida S, Okada K, Suginohara T, Nakao H, et al. Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects. J Nutr Sci Vitaminol (Tokyo). 1983;29(3):271–81.
   PubMed Web of Science ®Google Scholar
• Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, et al. The effect of dietary supplementation with n—3 polyunsaturated fatty acids on the synthesis of Interleukin-1 and Tumor Necrosis factor by Mononuclear cells. N Engl J Med. 1989;320(5):265–71.
   PubMed Web of Science ®Google Scholar
• Germano M, Meleleo D, Montorfano G, Adorni L, Negroni M, Berra B, et al. Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD). Nutr Neurosci. 2007;10(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Baidal DA, Sanchez J, Alejandro R, Blaschke CE, Hirani K, Matheson DL, et al. POSEIDON study: a pilot, safety and feasibility trial of high-dose omega 3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes. CellR4. 2018;6(1):e2489.
   Google Scholar
• Sears B, Bailes J, Asselin B. Therapeutic uses of high-dose omega-3 fatty acids to treat comatose patients with severe brain injury. PharmaNutrition. 2013;1:86–89.
   Google Scholar